Company

Not once, not twice...but thrice!

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.

RNS Investor Release

Oxehealth's Oxevision named one of 12 high impact innovations to join the NHS Innovation Accelerator in 2021.